About
Bird Rock Bio is a clinical-stage biopharmaceutical company developing immuno-inflammatory regulators and therapeutic antibodies targeting fibrotic and metabolic diseases such as diabetic nephropathy and NASH, using its proprietary iCAPS platform.
Explore Bird Rock Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.